Figure 4.
An example showing CCL2 enhancement of EPSCs was blocked by co-application of NMDA and AMPA receptor antagonists. All current traces were recorded from the same cell with a hold potential of −70mV. Bath co-application of APV (50 μM) and CNQX 10 μM completely blocked the effects of CCL2 enhancement of EPSCs.